We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


The Benefits of Constructing Leads from Fragment Hits

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "The Benefits of Constructing Leads from Fragment Hits"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Read time:

‘Fragments’ refer to particularly small molecular starting points in medicinal chemistry. The small size of fragments requires adapted techniques for their screening and subsequent elaboration. The detection of the weak binding affinity of fragments for their target, and associated screening issues, have been debated at length. The increasing ability to control and tailor this construction process highlights the potential benefits of fragment-based drug discovery.

This article is published online in Future Medicinal Chemistry and is free to view.